Clinical Outcomes of Liver Transplantation in Patients With Hepatorenal Syndrome: A Single Center Study in China

Fangcong Li, Tielong Wang, Liqiang Zhan, Zehua Jia, Tao Luo, Shirui Chen, Qiang Zhao, Zhiyong Guo, Xiaoshun He, Dongping Wang

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


Background: Liver transplantation (LT) is an optimal treatment for hepatorenal syndrome (HRS) patients but renal function recovery is not universal after operation. The aim of this study is to explore the association between stages of hepatorenal syndrome—acute kidney injury (HRS-AKI) and incidence of post-operation chronic kidney disease (CKD). Methods: Data of HRS-AKI patients who received LT were collected from the First Affiliated Hospital of Sun Yat-sen University from 2016 to 2020. A survival and incidence curve and multivariable model were established to analyze the impacts of HRS-AKI stages and variables on 90-day survival and CKD within 12 months. Results: A total of 62 HRS-AKI patients were enrolled in this study. Overall, 35 (57%), 17 (27%), and 10 (16%) patients were diagnosed as stages 1, 2, and 3, respectively. The patients at stage 3 had the poorest outcomes with the lowest rate of 90-day survival and the highest incidence of CKD in 12 months. Stage 3 (SHR = 7.186, 95% CI, 1.661–32.043) and postoperative renal replacement therapy (RRT) (SHR = 3.228, 95% CI, 1.115–9.345) were found as useful indicators for poor prognosis. Conclusions: In our study, the classification of HRS-AKI stages can be used to predict the prognosis of HRS patients after LT. The peak serum creatinine level is a risky predictor in high HRS-AKI stage patients.

Original languageEnglish (US)
Article number781648
JournalFrontiers in Surgery
StatePublished - Jan 28 2022


  • AKI
  • CKD
  • HRS
  • acute kidney injury
  • chronic kidney disease
  • hepatorenal syndrome
  • liver transplantation

ASJC Scopus subject areas

  • Surgery


Dive into the research topics of 'Clinical Outcomes of Liver Transplantation in Patients With Hepatorenal Syndrome: A Single Center Study in China'. Together they form a unique fingerprint.

Cite this